🇺🇸 FDA
Patent

US 9527903

Engineered antibody constant domain molecules

granted A61PA61P29/00A61P31/16

Quick answer

US patent 9527903 (Engineered antibody constant domain molecules) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P29/00, A61P31/16, A61P31/18, A61P35/00